Back to Search
Start Over
Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma
- Source :
- Urology Case Reports, Vol 40, Iss, Pp 101910-(2022), Urology Case Reports
- Publication Year :
- 2022
- Publisher :
- Elsevier, 2022.
-
Abstract
- Angiomyolipoma (AML) is a benign renal mass that can be treated with nephron sparing surgery or transarterial embolization. Embolization has been favored due to efficacy and safety profile. This case demonstrates a previously undocumented phenomenon of AML treated with transarterial embolization using Lipiodol® (Guerbet LLC, Princeton, NJ) resulting in nephrolithiasis and retention of Lipiodol® two years after original embolization. Although Lipiodol®-based embolization has not been shown to cause nephrolithiasis, it may have been the nidus for stone formation, and this is an important potential complication worthy of further study.
- Subjects :
- medicine.medical_specialty
Angiomyolipoma
Urology
medicine.medical_treatment
Embolization
medicine
Renal mass
Interventional radiology
medicine.diagnostic_test
business.industry
medicine.disease
Lipiodol®
Diseases of the genitourinary system. Urology
Lipiodol
Embolization material
Radiology
RC870-923
business
Complication
Endourology
Renal angiomyolipoma
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 22144420
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- Urology Case Reports
- Accession number :
- edsair.doi.dedup.....84b9edf0e4da6420ce20632b1f869f4d